Accessibility setting


Select language

Skip to secondary menu

Skip to content

Jehovah’s Witnesses


Beta Thalassemia (Pediatrics)

Beta Thalassemia Major—Transfusion Risks and Uncertainties

Marseillevirus prevalence in multitransfused patients suggests blood transmission.

Popgeorgiev N, Colson P, Thuret I, Chiarioni J, Gallian P, Raoult D, Desnues C.

Source‎: J Clin Virol 2013;58(4):722-5.

Indexed‎: PubMed 24183312

DOI‎: 10.1016/j.jcv.2013.10.001

Major causes of hospital admission in Beta thalassemia major patients in southern iran.

Karimi M, Emadmarvasti V, Hoseini J, Shoja L.

Source‎: Iran J Pediatr 2011;21(4):509-13.

Indexed‎: PubMed 23056840

A prospective study for prevalence and/or development of transfusion-transmitted infections in multiply transfused thalassemia major patients.

Jain R, Perkins J, Johnson ST, Desai P, Khatri A, Chudgar U, Choudhury N.

Source‎: Asian J Transfus Sci 2012;6(2):151-4.

Indexed‎: PubMed 22988380

DOI‎: 10.4103/0973-6247.98919

Seropositivity of hepatitis C, hepatitis B and HIV in chronically transfused β-thalassaemia major patients.

Ansari SH, Shamsi TS, Khan MT, Perveen K, Farzana T, Erum S, Ansari I.

Source‎: J Coll Physicians Surg Pak 2012;22(9):610-1.

Indexed‎: PubMed 22980623

DOI‎: 09.2012/JCPSP.610611

Post-transfusion hypertension, convulsion and intracranial haemorrhage in β-thalassemia major.

Masood SA, Zaidi A.

Source‎: J Coll Physicians Surg Pak 2012;22(7):473-5.

Indexed‎: PubMed 22747874

DOI‎: 07.2012/JCPSP.473475

Blood transfusion transmitted infections in multiple blood transfused patients of Beta thalassaemia.

Vidja PJ, Vachhani JH, Sheikh SS, Santwani PM.

Source‎: Indian J Hematol Blood Transfus 2011;27(2):65-9.

Indexed‎: PubMed 22654294

DOI‎: 10.1007/s12288-011-0057-3

Prevalence of alloimmunisation in patients with beta thalassaemia major.

Kosaryan M, Mahdavi MR, Roshan P, Hojjati MT.

Source‎: Blood Transfus 2012;10(3):396-7.

Indexed‎: PubMed 22395351

DOI‎: 10.2450/2012.0072-11

Clinical outcome of frequent exposure to Torque Teno virus (TTV) through blood transfusion in thalassemia patients with or without hepatitis C virus (HCV) infection.

Hu YW, Al-Moslih MI, Al Ali MT, Uzicanin S, Perkins H, Yi QL, Rahimi Khameneh S, Wu J, Brown EG.

Source‎: J Med Virol 2008;80(2):365-71.

Indexed‎: PubMed 18098140

Blood transfusion and lung function in children with thalassemia major.

Bacalo A, Kivity S, Heno N, Greif Z, Greif J, Topilsky M.

Source‎: Chest 1992;101(2):362-5.

Indexed‎: PubMed 1735255

Pulmonary dysfunction in transfusion-dependent patients with thalassemia major.

Carnelli V, D'Angelo E, Pecchiari M, Ligorio M, D'Angelo E.

Source‎: Am J Respir Crit Care Med 2003;168(2):180-4.

Indexed‎: PubMed 12738605

The medical section of is designed as an informational resource primarily for use by clinicians and other health-care professionals. It provides neither medical advice nor treatment recommendations and does not substitute for an appropriately qualified health-care provider. The clinical literature cited is not published by Jehovah’s Witnesses, but it outlines transfusion-alternative strategies that might be considered. It is the responsibility of each qualified health-care provider to maintain awareness of new information, discuss options for care, and assist patients in making choices in accord with their medical condition, wishes, values, and beliefs. Not all listed strategies are appropriate or acceptable to all patients.

Patients: Always seek the advice of your doctor or other qualified health-care provider regarding medical conditions or treatments. Check with a doctor if you suspect you are ill.

The use of this website is governed by its terms of use.